Headquarters: Cambridge, Massachusetts, United States
Trade prices
Volume:
Market Cap:4.67B
Prev closed:13.36
Open:13.87
High:13.91
Low:13.37
52 week low:9.18
52 week high:19
Dividends:No Dividends
Next ER:February 25, 2021 Before Market Opens
Top Stories (NTLA)
About the Company
Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and colleagues at University of California. The company has partnerships with Novartis and Regeneron.
Talk about Intellia Therapeutics Inc below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!
